Selecting the most effective antidepressant for patients can be a challenging process. Trial and error often leads to treatment delays, and no one likes to see their patients suffer through it. Enter pharmacogenetic testing – an approach designed to predict how a patient will respond to a particular antidepressant. But what is the science behind it? And more importantly, how reliable and practical is this in clinical settings?